Twist Bioscience Corporation Shares Outstanding (Cover Page)
Twist Bioscience Corporation (TWST) had Shares Outstanding (Cover Page) of 62.71 million shares as of 2026-07-29, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-03
- 2026-07-29: Entity Common Stock, Shares Outstanding 62.71M shares.
- 2026-04-29: Entity Common Stock, Shares Outstanding 62.27M shares.
- 2026-01-27: Entity Common Stock, Shares Outstanding 61.31M shares.
- 2025-11-13: Entity Common Stock, Shares Outstanding 61.15M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-29 | 62.71M shares 10-Q · filed 2026-08-03 |
| 2026-04-29 | 62.27M shares 10-Q · filed 2026-05-04 |
| 2026-01-27 | 61.31M shares 10-Q/A · filed 2026-02-26 |
| 2025-11-13 | 61.15M shares 10-K · filed 2025-11-17 |
| 2025-07-31 | 60.36M shares 10-Q · filed 2025-08-04 |
| 2025-05-01 | 59.92M shares 10-Q · filed 2025-05-05 |
| 2025-01-30 | 59.65M shares 10-Q · filed 2025-02-03 |
| 2024-11-13 | 59.36M shares 10-K · filed 2024-11-18 |
| 2024-07-31 | 58.59M shares 10-Q · filed 2024-08-02 |
| 2024-04-29 | 58.23M shares 10-Q · filed 2024-05-02 |
| 2024-01-29 | 57.82M shares 10-Q · filed 2024-02-02 |
| 2023-11-17 | 57.67M shares 10-K · filed 2023-11-21 |
| 2023-08-03 | 57.40M shares 10-Q · filed 2023-08-07 |
| 2023-05-04 | 57.15M shares 10-Q · filed 2023-05-08 |
| 2023-02-02 | 56.86M shares 10-Q · filed 2023-02-07 |
| 2022-11-23 | 56.57M shares 10-K/A · filed 2023-06-05 |
| 2022-11-18 | 56.57M shares 10-K · filed 2022-11-28 |
| 2022-08-04 | 56.36M shares 10-Q · filed 2022-08-08 |
| 2022-05-04 | 56.26M shares 10-Q · filed 2022-05-06 |
| 2022-02-07 | 50.89M shares 10-Q · filed 2022-02-09 |
| 2021-11-18 | 49.63M shares 10-K · filed 2021-11-23 |
| 2021-08-05 | 49.29M shares 10-Q · filed 2021-08-09 |
| 2021-05-05 | 48.89M shares 10-Q · filed 2021-05-07 |
| 2021-02-04 | 48.65M shares 10-Q · filed 2021-02-09 |
| 2020-11-23 | 45.15M shares 10-K · filed 2020-11-27 |
| 2020-08-10 | 44.66M shares 10-Q · filed 2020-08-12 |
| 2020-05-08 | 40.98M shares 10-Q · filed 2020-05-13 |
| 2020-02-06 | 35.45M shares 10-Q · filed 2020-02-10 |
| 2019-12-09 | 33.12M shares 10-K · filed 2019-12-13 |
| 2019-08-07 | 32.56M shares 10-Q · filed 2019-08-09 |
| 2019-04-29 | 28.04M shares 10-Q · filed 2019-05-02 |
| 2019-02-01 | 28.02M shares 10-Q · filed 2019-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |